| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Mereo BioPharma Group plc | Chief Patient Access and Commercial Planning | American Depositary Shares representing Ordinary Shares | 34.5K | $117K | $3.39 | Jun 26, 2024 | Direct |
| Mereo BioPharma Group plc | Chief Patient Access and Commercial Planning | Share Options (Right to buy) | 0 | $0 | $1.01 | May 22, 2024 | Direct |
| Mereo BioPharma Group plc | Chief Patient Access and Commercial Planning | Performance Based Restricted Stock Unit | 40K | Jun 21, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| MREO | Mereo BioPharma Group plc | Jun 25, 2024 | 2 | -$115K | 4 | Jun 27, 2024 | Chief Patient Access and Commercial Planning |
| MREO | Mereo BioPharma Group plc | Jun 21, 2024 | 2 | $0 | 4 | Jun 25, 2024 | Chief Patient Access and Commercial Planning |
| MREO | Mereo BioPharma Group plc | May 22, 2024 | 0 | $0 | 4/A | Jun 11, 2024 | Chief Patient Access and Commercial Planning |
| MREO | Mereo BioPharma Group plc | May 22, 2024 | 8 | -$383K | 4 | May 23, 2024 | Chief Patient Access and Commercial Planning |
| MREO | Mereo BioPharma Group plc | Jan 25, 2024 | 1 | $0 | 4 | Jan 26, 2024 | Chief Patient Access and Commercial Planning |
| MREO | Mereo Biopharma Group plc | Jan 1, 2024 | 0 | $0 | 3 | Jan 2, 2024 | Chief Patient Access and Commercial Planning Exhibit 24 - Power of Attorney |